AGILENT TECHNOLOGIES, INC. (A) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-31..
Quick ratio
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.29B USD | Liabilities, Current |
| Cash and equivalents | 1.76B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.48B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 1.12B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | (m) | $2.29B | $1.76B | (m) | $1.48B | $1.12B | (m) |
| 2026-04-30 | (m) | $2.27B | $1.81B | (m) | $1.50B | $1.09B | (m) |
| 2026-01-31 | (m) | $2.23B | $1.76B | (m) | $1.52B | $1.06B | (m) |
| 2025-10-31 | (m) | $2.35B | $1.79B | (m) | $1.49B | $1.02B | (m) |
| 2025-07-31 | (m) | $1.89B | $1.53B | (m) | $1.38B | $1.01B | (m) |
| 2025-04-30 | (m) | $2.01B | $1.49B | (m) | $1.37B | $991.00M | (m) |
| 2025-01-31 | (m) | $1.87B | $1.47B | (m) | $1.33B | $997.00M | (m) |
| 2024-10-31 | (m) | $1.90B | $1.33B | (m) | $1.32B | $972.00M | (m) |
| 2024-07-31 | (m) | $2.39B | $1.78B | (m) | $1.23B | $978.00M | (m) |
| 2024-04-30 | (m) | $1.96B | $1.67B | (m) | $1.25B | $1.00B | (m) |
| 2024-01-31 | (m) | $1.62B | $1.75B | (m) | $1.29B | $1.03B | (m) |
| 2023-10-31 | (m) | $1.60B | $1.59B | (m) | $1.29B | $1.03B | (m) |
| 2023-07-31 | (m) | $1.76B | $1.33B | (m) | $1.34B | $1.07B | (m) |
| 2023-04-30 | (m) | $1.67B | $1.18B | (m) | $1.40B | $1.10B | (m) |
| 2023-01-31 | (m) | $1.94B | $1.25B | (m) | $1.46B | $1.11B | (m) |
| 2022-10-31 | (m) | $1.86B | $1.05B | (m) | $1.41B | $1.04B | (m) |
| 2022-07-31 | (m) | $1.90B | $1.07B | (m) | $1.34B | $1.01B | (m) |
| 2022-04-30 | (m) | $1.81B | $1.19B | (m) | $1.24B | $937.00M | (m) |
| 2022-01-31 | (m) | $1.58B | $1.11B | (m) | $1.21B | $879.00M | (m) |
| 2021-10-31 | (m) | $1.71B | $1.48B | (m) | $1.17B | $830.00M | (m) |
| 2021-07-31 | (m) | $1.72B | $1.43B | (m) | $1.12B | $818.00M | (m) |
| 2021-04-30 | (m) | $1.76B | $1.38B | (m) | $1.07B | $791.00M | (m) |
| 2021-01-31 | (m) | $1.69B | $1.33B | (m) | $1.09B | $755.00M | (m) |
| 2020-10-31 | (m) | $1.47B | $1.44B | (m) | $1.04B | $720.00M | (m) |
| 2020-07-31 | (m) | $1.31B | $1.36B | (m) | $930.00M | $746.00M | (m) |
| 2020-04-30 | (m) | $1.95B | $1.32B | (m) | $886.00M | $750.00M | (m) |
| 2020-01-31 | (m) | $1.89B | $1.23B | (m) | $966.00M | $706.00M | (m) |
| 2019-10-31 | (m) | $2.08B | $1.38B | (m) | $930.00M | $679.00M | (m) |
| 2019-07-31 | (m) | $1.62B | $1.76B | (m) | $856.00M | $660.00M | (m) |
| 2019-04-30 | (m) | $1.12B | $2.15B | (m) | $819.00M | $657.00M | (m) |
| 2019-01-31 | (m) | $1.09B | $2.06B | (m) | $833.00M | $653.00M | (m) |
| 2018-11-01 | (m) | $1.16B | $2.25B | (m) | $800.00M | $628.00M | (m) |
| 2018-10-31 | (m) | $1.17B | $2.25B | (m) | $776.00M | $638.00M | (m) |
| 2018-07-31 | (m) | $1.01B | $2.13B | (m) | $733.00M | $623.00M | (m) |
| 2018-04-30 | (m) | $1.36B | $3.01B | (m) | $754.00M | $594.00M | (m) |
| 2018-01-31 | (m) | $1.36B | $2.89B | (m) | $751.00M | $608.00M | (m) |
| 2017-10-31 | (m) | $1.26B | $2.68B | (m) | $724.00M | $575.00M | (m) |
| 2017-07-31 | (m) | $1.24B | $2.56B | (m) | $678.00M | $566.00M | (m) |
| 2017-04-30 | (m) | $1.19B | $2.39B | (m) | $677.00M | $548.00M | (m) |
| 2017-01-31 | (m) | $1.09B | $2.24B | (m) | $653.00M | $551.00M | (m) |
| 2016-10-31 | (m) | $945.00M | $2.29B | (m) | $631.00M | $533.00M | (m) |
| 2016-07-31 | (m) | $1.15B | $2.20B | (m) | $590.00M | $543.00M | (m) |
| 2016-04-30 | (m) | $1.13B | $2.14B | (m) | $602.00M | $555.00M | (m) |
| 2016-01-31 | (m) | $947.00M | $1.93B | (m) | $617.00M | $554.00M | (m) |
| 2015-10-31 | (m) | $976.00M | $2.00B | (m) | $606.00M | $541.00M | (m) |
| 2015-07-31 | (m) | $853.00M | $2.08B | (m) | $584.00M | $545.00M | (m) |
| 2015-04-30 | (m) | $930.00M | $2.20B | (m) | $576.00M | $556.00M | (m) |
| 2015-01-31 | (m) | $928.00M | $2.12B | (m) | $615.00M | $560.00M | (m) |
| 2014-10-31 | (m) | $1.70B | $3.03B | (m) | $983.00M | $1.07B | (m) |
| 2014-07-31 | (m) | $1.58B | $2.39B | (m) | $891.00M | $1.10B | (m) |
| 2014-04-30 | (m) | $1.72B | $2.95B | (m) | $903.00M | $1.10B | (m) |
| 2014-01-31 | (m) | $1.55B | $2.74B | (m) | $849.00M | $1.09B | (m) |
| 2013-10-31 | (m) | $1.60B | $2.67B | (m) | $899.00M | $1.07B | (m) |
| 2013-07-31 | (m) | $1.55B | $2.33B | (m) | $875.00M | $1.05B | (m) |
| 2013-04-30 | (m) | $1.91B | $2.52B | (m) | $916.00M | $1.04B | (m) |
| 2013-01-31 | (m) | $1.85B | $2.45B | (m) | $874.00M | $1.04B | (m) |
| 2012-10-31 | (m) | $1.89B | $2.35B | (m) | $923.00M | $1.01B | (m) |
| 2012-07-31 | (m) | $2.09B | $1.92B | (m) | $950.00M | $1.04B | (m) |
| 2012-04-30 | (m) | $1.83B | $3.90B | (m) | $909.00M | $947.00M | (m) |
| 2012-01-31 | (m) | $1.71B | $3.66B | (m) | $814.00M | $937.00M | (m) |
| 2011-10-31 | (m) | $1.84B | $3.53B | (m) | $860.00M | $898.00M | (m) |
| 2011-07-31 | (m) | $1.50B | $3.10B | (m) | $917.00M | $897.00M | (m) |
| 2011-04-30 | (m) | $1.59B | $2.98B | (m) | $918.00M | $853.00M | (m) |
| 2011-01-31 | (m) | $1.41B | $2.64B | (m) | $854.00M | $797.00M | (m) |
| 2010-10-31 | (m) | $3.08B | $2.65B | (m) | $869.00M | $716.00M | (m) |
| 2010-07-31 | (m) | $2.92B | $2.32B | (m) | $790.00M | $688.00M | (m) |
| 2010-04-30 | (m) | $2.71B | $2.65B | (m) | $669.00M | $546.00M | (m) |
| 2010-01-31 | (m) | $2.55B | $2.48B | (m) | $628.00M | $548.00M | (m) |
| 2009-10-31 | (m) | $1.12B | $2.48B | (m) | $595.00M | $552.00M | (m) |
| 2009-07-31 | (m) | $991.00M | $1.48B | (m) | $544.00M | $571.00M | (m) |
| 2009-04-30 | (m) | (m) | $1.40B | (m) | (m) | (m) | (m) |
| 2009-01-31 | (m) | (m) | $1.36B | (m) | (m) | (m) | (m) |
| 2008-10-31 | (m) | $1.33B | $1.41B | (m) | $770.00M | $646.00M | (m) |
| 2008-07-31 | (m) | (m) | $1.64B | (m) | (m) | (m) | (m) |
| 2007-10-31 | (m) | (m) | $1.83B | (m) | (m) | (m) | (m) |
| 2006-10-31 | (m) | (m) | $2.26B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |